Evaluation of Closed Incision Negative Pressure Dressing (PREVENA) to Prevent Lower Extremity Amputation Wound Complications



Status:Recruiting
Conditions:Hospital, Hospital
Therapuetic Areas:Other
Healthy:No
Age Range:18 - Any
Updated:3/8/2019
Start Date:January 15, 2019
End Date:December 15, 2021
Contact:Laura Anatale-Tardiff
Email:laura.anatale.tardiff@jefferson.edu
Phone:2155034280

Use our guide to learn which trials are right for you!

This study is a prospective, multi-center, two-arm, unblinded, and randomized controlled
trial with a goal of evaluating the impact of a closed incision negative pressure dressing
(PREVENA) on incidence of post-operative wound complications and medical costs in patients
undergoing lower extremity amputation.

This is a prospective, multi-center, two-arm, unblinded, randomized controlled trial to
evaluate the impact of a closed incision negative pressure dressing (PREVENA™ PEEL & PLACE™
Dressing Kit) on incidence of post-operative wound complications in patients undergoing
above-the-knee (AKA) or below-the-knee (BKA) amputation. Up to 440 subjects at approximately
five (5) participating sites will be randomized to receive either the Prevena dressing or a
standard care dressing. The incision will be assessed for complications at post-op day 5 or
day 6 and at approximately 30 days after discharge. The primary outcome of this study is
reported wound complications, including dehiscence (opening of the incision), seroma, lymph
leak, infection (deep or superficial), hematoma (blood clots), ischemia (decreased blood
supply), and necrosis (tissue death) A major complication is defined as any wound
complication requiring intravenous or oral antibiotics, reoperation and/or hospital
readmission. All data (demographics, medical history, and clinical outcomes) will be
collected via medical record review

Inclusion Criteria:

1. Male or female adults 18 years or older

2. Patients undergoing above-knee amputation (includes the revision of emergency
guillotine amputations)

3. Patients undergoing below-knee amputation (includes the revision of emergency
guillotine amputations)

4. Informed Consent signed by patient

Exclusion Criteria:

1. Minors under 18 years

2. Women who are pregnant or breastfeeding

3. Patients undergoing emergent or guillotine amputation

4. Patients having BOTH legs amputated

5. Patients with sensitivity to silver

6. Unwilling or unable to provide informed consent

7. Inability to comply with planned study procedures
We found this trial at
5
sites
111 S 11th St
Philadelphia, Pennsylvania 19107
(215) 955-6000
Principal Investigator: Paul DiMuzio, MD
Phone: 215-503-4280
Thomas Jefferson University Hospital Our hospitals in Center City Philadelphia share a 13-acre campus with...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Abington, Pennsylvania 19001
Principal Investigator: Danielle Pineda, MD
Phone: 215-887-5934
?
mi
from
Abington, PA
Click here to add this to my saved trials
Roma, RM 80016
Principal Investigator: Raffaele Landolfi, MD
?
mi
from
Roma,
Click here to add this to my saved trials
Syracuse, New York 13210
Principal Investigator: Michael Costanza, MD
?
mi
from
Syracuse, NY
Click here to add this to my saved trials
Valhalla, New York 10595
Principal Investigator: Jeontaik Kwon, MD
?
mi
from
Valhalla, NY
Click here to add this to my saved trials